Sr. Director - HEMAR, Americas Region Head
Vantive
Summary
The Sr. Director - HEMAR, Americas Region Head role has a dual responsibility across the Chronic and Acute portfolios BUs: responsible for reimbursement and policy strategies across the Americas region; direct line management of HEMAR leads in the Americas region; leadership of the HEMAR strategy for the Americas region by coordinating with the local marketing and sales organizations, driving economic evidence dissemination and value strategies with Payers and Providers; input into strategic and business planning activities of both Chronic and Acute organizations; represents the voice of non-clinical stakeholders in the Americas Region, establishes the access and evidence requirements for successful new product development and introduction, collaborates closely with R&D, Upstream Marketing and Medical Affairs. This position reports directly to VP Global HEMAR and will work in close collaboration with multiple internal partners and stakeholders, including Global and local HEMAR teams, Marketing teams and Sales leadership, Medical Affairs and R&D.
Job description
Position Duties & Responsibilities
- Lead HEMAR Strategy for the Americas (including policy, reimbursement and HTA)
- Direct line management of HEMAR team in the Americas region
- Responsibility for economic evidence dissemination to payers and providers and building capability across the commercial (evidence-based selling) and Medical Affairs organization
- Strategic partner for New Product Development (R&D) value proposition: non-clinical stakeholder dimension, value-based pricing, target product profile (TPP)
- Lead economic evidence generation projects in the region (Outcomes Research)
Market Access Assessment & Strategy
- Understand the healthcare environment (including reimbursement, policy), the external marketplace and market access requirements in North America as well as other key geographies in the Americas region, with proven experience in Brazil and Mexico
- Develop strategies for market access and adoption in the region
- Provide inputs to relevant new product development, life-cycle optimization, licensing & acquisition
- Support execution of commercial strategies with global/regional/country commercial partners
- Understand commercial financial information related to the business, KPIs and financial forecasting metrics and trends impacted by market access, funding and reimbursement
Strategic Thinking and Innovation
- Apply HEMAR perspectives and knowledge to current and future portfolio and solution planning to deliver mid and long-term business success
- Working with cross-functional teams to develop a clear set of goals and plans
- Understand and shape innovation strategy to optimize value, access and adoption
- Assess, shape and plan for quantifying potential value propositions and TPPs for NPD to optimize market access and adoption
- Integration of value-based thinking and market access requirements into strategies, TPPs and Vantive Evidence Generation Strategies
Requirements
- Proven experience in North America and key geographies in the region including Mexico and Brazil: Health Economics and Outcomes Research, Health Technology Assessment, Market Access, Real World Evidence, Reimbursement
- International experience, leading various markets or regions is highly preferred (worked or supported in at least two different markets, one of them being NA)
- Minimum of 10 years in space of Health Economics and Market Access
- People Management experience of 5 plus years
- Advanced degree (MS, MPH, PhD) in a health economics related subject
Benefits
- Medical, Dental & Vision
- Life & Accident Insurance
- Short & Long-Term Disability
- 401(k) Retirement Plan
- Flexible Spending Accounts
- Educational Assistance
- Paid Holidays
- Paid Time Off
- Paid Parental Leave
- Commuting Benefits
- Employee Discount Program
- Employee Assistance Program
- Childcare Benefits
Company overview
Vantive is a leading vital organ therapy company that emerged as an independent entity following its acquisition by Carlyle Group from Baxter International in January 2025. Building on a 70-year legacy of kidney care innovation, Vantive specializes in developing and manufacturing advanced medical equipment for dialysis and vital organ support. The company's comprehensive product portfolio includes peritoneal dialysis systems, hemodialysis equipment, continuous renal replacement therapy (CRRT) solutions, and digital health platforms. Operating in over 100 countries worldwide, Vantive delivers more than 1 million patient touchpoints daily through its innovative technologies and services. The company focuses on transforming vital organ therapies by enhancing accessibility, improving patient outcomes, and providing flexible treatment options for both home and clinical settings. With a mission to extend lives and expand possibilities, Vantive combines decades of clinical expertise with cutting-edge digital solutions to address the complex needs of patients with chronic kidney disease and acute organ failure.